Dr.seq2: A quality control and analysis pipeline for parallel single cell transcriptome and epigenome data

• Chengchen Zhao,

  Affiliation Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Science and Technology, Shanghai Key Laboratory of Signaling and Disease Research, Tongji University, Shanghai, China

  ⨯
• Sheng’en Hu,

  Affiliation Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Science and Technology, Shanghai Key Laboratory of Signaling and Disease Research, Tongji University, Shanghai, China

  ⨯
• Xiao Huo,

  Affiliation Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Science and Technology, Shanghai Key Laboratory of Signaling and Disease Research, Tongji University, Shanghai, China

  ⨯
• Yong Zhang

  * E-mail: yzhang@tongji.edu.cn

  Affiliation Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Science and Technology, Shanghai Key Laboratory of Signaling and Disease Research, Tongji University, Shanghai, China

  http://orcid.org/0000-0001-6316-2734

  ⨯